These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10439523)

  • 61. Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis: a case series.
    Scheel PJ; Feeley N; Sozio SM
    Ann Intern Med; 2011 Jan; 154(1):31-6. PubMed ID: 21200036
    [TBL] [Abstract][Full Text] [Related]  

  • 62. High mycophenolic acid area under-the-curve values in renal transplant recipients on long-term mycophenolate mofetil treatment.
    Engelbertink R; Smak Gregoor P; Hesse C; IJzermans J; Weimar W; van Gelder T
    Transplant Proc; 2002 Nov; 34(7):2983-4. PubMed ID: 12431677
    [No Abstract]   [Full Text] [Related]  

  • 63. Improved primary transplant success rates using a triple regimen of cyclosporine microemulsion, mycophenolate mofetil and prednisone.
    Khauli RB; Medawar WA; Habbal AA; Birbari AE; Daouk MM; Abdelnoor AM; Uwaydah M; Rahman Bizri A; Sanjad S; Ayvazian PJ; Lovewell T; Stoff JS; Yang Fan P; Bigwood P; Harland R
    Transplant Proc; 2001 Aug; 33(5):2776-7. PubMed ID: 11498156
    [No Abstract]   [Full Text] [Related]  

  • 64. Empiric therapy of autoimmune hepatitis with mycophenolate mofetil: comparison with conventional treatment for refractory disease.
    Czaja AJ; Carpenter HA
    J Clin Gastroenterol; 2005 Oct; 39(9):819-25. PubMed ID: 16145346
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil: complete report on 350 primary adult liver transplantations.
    Jain A; Kashyap R; Kramer D; Dodson F; Hamad I; Starzl TE; Fung JJ
    Transplant Proc; 2001; 33(1-2):1342-4. PubMed ID: 11267319
    [No Abstract]   [Full Text] [Related]  

  • 66. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents.
    Menter A; Korman NJ; Elmets CA; Feldman SR; Gelfand JM; Gordon KB; Gottlieb AB; Koo JY; Lebwohl M; Lim HW; Van Voorhees AS; Beutner KR; Bhushan R
    J Am Acad Dermatol; 2009 Sep; 61(3):451-85. PubMed ID: 19493586
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Treatment of lupus nephritis].
    Novak S
    Lijec Vjesn; 2014; 136(7-8):215-9. PubMed ID: 25327009
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Treatment of steroid-dependent minimal change-nephrotic syndrome with mycophenolate mofetil].
    Noroña B; Valentín M; Gutiérrez E; Praga M
    Nefrologia; 2004; 24(1):79-82. PubMed ID: 15083963
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mycophenolic acid in dermatology a century after its discovery.
    Strathie Page SJ; Tait CP
    Australas J Dermatol; 2015 Feb; 56(1):77-83. PubMed ID: 25557632
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy.
    Inductivo-Yu I; Adams A; Gish RG; Wakil A; Bzowej NH; Frederick RT; Bonacini M
    Clin Gastroenterol Hepatol; 2007 Jul; 5(7):799-802. PubMed ID: 17509945
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Reduced-dose cyclosporine with mycophenolate mofetil and prednisone significantly improves the long-term glomerular filtration rate and graft survival.
    Wang R; Xu Y; Wu J; Wang Y; He Q; Chen J
    Intern Med; 2013; 52(9):947-53. PubMed ID: 23648712
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Successful use of mycophenolate mofetil to treat severe chronic urticaria in a patient intolerant to ciclosporin.
    Raghavendran RR; Humphreys F; Kaur MR
    Clin Exp Dermatol; 2014 Jan; 39(1):68-9. PubMed ID: 23692555
    [No Abstract]   [Full Text] [Related]  

  • 73. [Mycophenolate mofetil in lupus nephritis treatment].
    Savio V; Alba P; Babini AM
    Rev Fac Cien Med Univ Nac Cordoba; 2012; 69(4):219-23. PubMed ID: 23751789
    [No Abstract]   [Full Text] [Related]  

  • 74. A prospective, randomized trial of tacrolimus/prednisone vs tacrolimus/prednisone/mycophenolate mofetil in renal transplantation: 1-year actuarial follow-up.
    Shapiro R; Jordan ML; Scantlebury VP; Vivas C; Marsh JW; McCauley J; Johnston J; Randhawa P; Irish W; Gritsch HA; Naraghi R; Hakala TR; Fung JJ; Starzl TE
    Transplant Proc; 1999; 31(1-2):1134. PubMed ID: 10083507
    [No Abstract]   [Full Text] [Related]  

  • 75. Combination therapy of mycophenolate mofetil and tacrolimus in lupus nephritis.
    Lanata CM; Mahmood T; Fine DM; Petri M
    Lupus; 2010 Jul; 19(8):935-40. PubMed ID: 20388722
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis.
    Scheel PJ; Piccini J; Rahman MH; Lawler L; Jarrett T
    J Urol; 2007 Jul; 178(1):140-3; discussion 143-4. PubMed ID: 17499287
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mycophenolate mofetil for treatment of active inflammatory bowel disease. Clinical and immunological studies.
    Neurath MF; Wanitschke R; Peters M; Hildner K; Tufan R; Meyer zum Büschenfelde KH; Schlaak JF
    Ann N Y Acad Sci; 1998 Nov; 859():315-8. PubMed ID: 9928412
    [No Abstract]   [Full Text] [Related]  

  • 78. A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.
    Li X; Tian J; Wu J; He Q; Li H; Han F; Li Q; Chen Y; Ni Q; Chen J
    Clin Ther; 2009 Apr; 31(4):741-50. PubMed ID: 19446147
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mycophenolic acid for lymphomatoid papulosis.
    Champagne T; Walsh S
    J Cutan Med Surg; 2013; 17(5):332-4. PubMed ID: 24067853
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial.
    Hou JH; Le WB; Chen N; Wang WM; Liu ZS; Liu D; Chen JH; Tian J; Fu P; Hu ZX; Zeng CH; Liang SS; Zhou ML; Zhang HT; Liu ZH
    Am J Kidney Dis; 2017 Jun; 69(6):788-795. PubMed ID: 28215945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.